Biotech · Private company · New York, NY, US
Aspargo Labs, Inc.
SEC CIK 0001805092
Track this companyFree. Adds Aspargo Labs, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ASP-001Phase 1 · Erectile DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- ASP-001.1Phase 1 · Erectile DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- Commercial Sildenafil and Sildenafil/Tadalafil ProductsPhase 1 · Erectile DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- ViagraPhase 1 · Erectile DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Hezkue®, Hezkue Turbo®, and Commercial Sildenafil Products in Fed Healthy Male SubjectPHASE1 · NOT_YET_RECRUITING · started Jan 1, 2026ClinicalTrials.gov NCT07117383 · fetched Nov 12, 2026
- The Objective of This Phase 1 Study is to Evaluate the Food Effect of 100 mg Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fed Versus 100 mg of Hezkue Turbo® (ASP-001.1, Sildenafil) Under Fasted Conditions in Healthy Adult Male SubjectsPHASE1 · RECRUITING · started Apr 15, 2025ClinicalTrials.gov NCT06872866 · fetched Nov 12, 2026
- Study to Compare the Effects of Viagra® Vs Hezkue® in Healthy Fasted Male Participants.PHASE1 · NOT_YET_RECRUITING · started Jan 1, 2025ClinicalTrials.gov NCT06782659 · fetched Nov 12, 2026